Literature DB >> 16054060

Roles for leptin receptor/STAT3-dependent and -independent signals in the regulation of glucose homeostasis.

Sarah H Bates1, Rohit N Kulkarni, Matthew Seifert, Martin G Myers.   

Abstract

Leptin activates the long form of the leptin receptor (LRb) to control feeding and neuroendocrine function and thus regulate adiposity. While adiposity influences insulin sensitivity, leptin also regulates glucose homeostasis independently of energy balance. Disruption of the LRb/STAT3 signal in s/s mice results in hyperphagia, neuroendocrine dysfunction, and obesity similar to LRb null db/db mice. Insulin resistance and glucose intolerance are improved in s/s compared to db/db animals, however, suggesting that LRb/STAT3-independent signals may contribute to the regulation of glucose homeostasis by leptin. Indeed, caloric restriction normalized glycemic control in s/s animals, but db/db mice of similar weight and adiposity remained hyperglycemic. These differences in glucose homeostasis were not attributable to differences in insulin production between s/s and db/db animals but rather to decreased insulin resistance in s/s mice. Thus, in addition to LRb/STAT3-mediated adiposity signals, non-LRb/STAT3 leptin signals mediate an important adiposity-independent role in promoting glycemic control.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16054060     DOI: 10.1016/j.cmet.2005.02.001

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  59 in total

1.  Disruption of hypothalamic leptin signaling in mice leads to early-onset obesity, but physiological adaptations in mature animals stabilize adiposity levels.

Authors:  Laurence E Ring; Lori M Zeltser
Journal:  J Clin Invest       Date:  2010-07-01       Impact factor: 14.808

2.  Leptin action via LepR-b Tyr1077 contributes to the control of energy balance and female reproduction.

Authors:  Christa M Patterson; Eneida C Villanueva; Megan Greenwald-Yarnell; Michael Rajala; Ian E Gonzalez; Natinder Saini; Justin Jones; Martin G Myers
Journal:  Mol Metab       Date:  2012-07-26       Impact factor: 7.422

Review 3.  Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells.

Authors:  Shanchun Guo; Mingli Liu; Guangdi Wang; Marta Torroella-Kouri; Ruben R Gonzalez-Perez
Journal:  Biochim Biophys Acta       Date:  2012-01-24

4.  Critical role of STAT3 in leptin's metabolic actions.

Authors:  Christoph Buettner; Alessandro Pocai; Evan D Muse; Anne M Etgen; Martin G Myers; Luciano Rossetti
Journal:  Cell Metab       Date:  2006-07       Impact factor: 27.287

5.  Differences in metabolomic profiles of male db/db and s/s, leptin receptor mutant mice.

Authors:  Nadia Saadat; Heidi B IglayReger; Martin G Myers; Peter Bodary; Smiti V Gupta
Journal:  Physiol Genomics       Date:  2012-02-07       Impact factor: 3.107

6.  Effect of leptin on intestinal re-growth following massive small bowel resection in rat.

Authors:  Igor Sukhotnik; Zahava Vadasz; Arnold G Coran; Michael Lurie; Eitan Shiloni; Ossama A Hatoum; Jorge G Mogilner
Journal:  Pediatr Surg Int       Date:  2006-01       Impact factor: 1.827

Review 7.  Hypothalamic leptin regulation of energy homeostasis and glucose metabolism.

Authors:  Gregory J Morton
Journal:  J Physiol       Date:  2007-06-21       Impact factor: 5.182

Review 8.  Adipokines and insulin resistance.

Authors:  Katja Rabe; Michael Lehrke; Klaus G Parhofer; Uli C Broedl
Journal:  Mol Med       Date:  2008-09-17       Impact factor: 6.354

9.  Changes in insulin sensitivity during leptin replacement therapy in leptin-deficient patients.

Authors:  Gilberto Paz-Filho; Karin Esposito; Barry Hurwitz; Anil Sharma; Chuanhui Dong; Victor Andreev; Tuncay Delibasi; Halil Erol; Alejandro Ayala; Ma-Li Wong; Julio Licinio
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-14       Impact factor: 4.310

10.  Role of proopiomelanocortin neuron Stat3 in regulating arterial pressure and mediating the chronic effects of leptin.

Authors:  John H Dubinion; Jussara M do Carmo; Ahmad Adi; Shereen Hamza; Alexandre A da Silva; John E Hall
Journal:  Hypertension       Date:  2013-03-25       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.